Exact Mass: 506.1665
Exact Mass Matches: 506.1665
Found 84 metabolites which its exact mass value is equals to given mass value 506.1665
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Dimethyl 3,3'-(6-methoxy-6-oxohex-1-ene-1,1-diyl)bis(5-cyano-6-methoxybenzoate)
3-Benzo[1,3]dioxol-5-yl-5-hydroxy-5-(4-methoxy-phenyl)-4-(3,4,5-trimethoxy-benzyl)-5H-furan-2-one
Me glycoside,penta-Ac-alpha-Pyranose-3-O-beta-L-Arabinopyranosyl-L-arabinose
Syringic acid methyl ester 4-O-beta-D-apiofuranosyl-(1->2)-beta-D-glucopyranoside|Syringic acid methyl ester-4-O-??-D-apiofuranosyl-(1鈥樏傗垎2)-??-D-glucopyranoside
3,4-methylendioxymethylrocaglate|4-demethoxy-3,4-methylenedioxymethyl rocaglate|Rocaglamide derivative 8
syringic acid 4-O-beta-D-glucopyranosyl-(1?5)-alpha-L-rhamnopyranoside
Me glycoside,penta-Ac-beta-Pyranose-4-O-alpha-D-Xylopyranosyl-D-xylose
Me glycoside,penta-Ac-alpha-Pyranose-2-O-beta-D-Xylopyranosyl-D-xylose
[(2R,3R,4S,5R,6S)-4,5-dibenzoyloxy-2-(hydroxymethyl)-6-methoxyoxan-3-yl] benzoate
Darifenacin HBr
C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018680 - Cholinergic Antagonists D000089162 - Genitourinary Agents > D064804 - Urological Agents Darifenacin hydrobromide (UK-88525 hydrobromide) is a selective M3 muscarinic receptor antagonist with a pKi of 8.9.
C21H30O14_2,3,4,5,6-Pentahydroxycyclohexyl 4-O-(4-hydroxy-2-methoxy-6-methylbenzoyl)hexopyranoside
C21H30O14_4-{[1-(Hexopyranosyloxy)-4-(methoxycarbonyl)-7-methyl-1,4a,5,6,7,7a-hexahydrocyclopenta[c]pyran-6-yl]oxy}-3-hydroxy-4-oxobutanoic acid
METHYL 2,3,4-TRI-O-BENZOYL-ALPHA-D-GLUCOPYRANOSIDE
methyl 2,3,6-tri-o-benzoyl-alpha-d-galactopyranoside
2-[N-(2-acetoxyethyl)-4-chloro-2-nitro-5-[2-(propionamido)anilino]anilino]ethyl acetate
4-fluoro-N-[2-[4-(2-methoxyphenyl)piperazin-1-yl]ethyl]-N-pyridin-2-ylbenzamide,dihydrochloride
Methyl 2,3,6-tri-O-benzoyl-alpha-D-mannopyranoside
1-[N-[6-[[amino-[(4-chlorophenyl)carbamoylamino]methylidene]amino]hexyl]carbamimidoyl]-3-(4-chlorophenyl)urea
3-Benzo[1,3]dioxol-5-yl-5-hydroxy-5-(4-methoxy-phenyl)-4-(3,4,5-trimethoxy-benzyl)-5H-furan-2-one
2-[(2S,4aR,12aS)-5-methyl-6-oxo-8-[[oxo-[4-(trifluoromethyl)phenyl]methyl]amino]-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]acetic acid methyl ester
[(E)-4-[5-[3-[2,4-dihydroxy-5-(3-methylbut-2-enyl)phenyl]-2-hydroxy-3-oxopropyl]-2-hydroxyphenyl]-2-methylbut-2-enyl] hydrogen sulate
[(4s)-3-[(1s)-1-(acetyloxy)ethyl]-2-{[(2s,3r,4s,5s,6r)-6-[(acetyloxy)methyl]-3,4,5-trihydroxyoxan-2-yl]oxy}-5-(methoxycarbonyl)-3,4-dihydro-2h-pyran-4-yl]acetic acid
(1s,4as,7ar)-7-methyl-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-4a-{[(2s,3s,4s,5r,6s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,7ah-cyclopenta[c]pyran-5-one
(3r,4s,5s,6r)-4,5-dihydroxy-6-{[(9s)-4,5,9-trihydroxy-2-methyl-10-oxoanthracen-9-yl]methyl}oxan-3-yl benzoate
methyl (10s,11r,12r,13s,14r)-10,11-dihydroxy-8-methoxy-14-(4-methoxyphenyl)-13-phenyl-4,6,15-trioxatetracyclo[7.6.0.0³,⁷.0¹⁰,¹⁴]pentadeca-1,3(7),8-triene-12-carboxylate
(1s,4s,5s,8as,12s,12as)-4-hydroxy-1,4,5-trimethyl-3,7-dioxo-12-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,5h,8h,8ah,12h,12ah-pyrano[3,4-g][1,5]dioxecine-9-carboxylic acid
3-(formyloxy)-2-hydroxy-10,12-dimethoxy-6-(4-methoxyphenyl)-5-phenyl-7-oxatricyclo[6.4.0.0²,⁶]dodeca-1(12),8,10-triene-4-carboxylic acid
6'-o-α-l-arabinopyranosylswertiamarin
{"Ingredient_id": "HBIN012631","Ingredient_name": "6'-o-\u03b1-l-arabinopyranosylswertiamarin","Alias": "NA","Ingredient_formula": "C21H30O14","Ingredient_Smile": "C=CC1C(OC=C2C1(CCOC2=O)O)OC3C(C(C(C(O3)COC4C(C(C(CO4)O)O)O)O)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "1593","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}